CIK 0001896212 · <br>Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 873272543
- Phone
- (646) 491 9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 2 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | Taylor Mark Andrew 10% owner | Other disposition · Pre-Funded Warrants | −9,968,931 | 14,609,501 | ||
| 2026-02-19 | Farley Chele Chiavacci Director | Grant or award | +10,553 | $1.04 | $11K | 17,157 |
| 2026-02-19 | Farley Chele Chiavacci Director | Grant or award · Pre-Funded Warrants | +1,940,804 | $1.04 | $2.0M | 1,940,804 |
| 2025-12-08 | Regan Andrew Chief Executive Officer | Grant or award | +224,800 | $1.79 | $402K | 227,304 |
| 2025-12-08 | Regan Andrew Chief Executive Officer | Grant or award · Pre-Funded Warrants | +3,685,815 | $0.00 | $369 | 3,685,815 |
| 2025-09-19 | Regan Andrew Chief Executive Officer | Grant or award | +1,120,000 | $0.69 | $769K | 1,120,044 |
| 2025-09-19 | Bligh James CFO | Grant or award | +480,000 | 480,024 | ||
| 2025-08-12 | Fry Simon Jeremy Director | Grant or award | +35,000 | 36,956 | ||
| 2025-08-12 | Lewis-Hall Freda C Director | Grant or award | +35,000 | 38,466 | ||
| 2025-08-12 | Farley Chele Chiavacci Director | Grant or award | +35,000 | 37,369 | ||
| 2025-08-05 | Fry Simon Jeremy Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-08-05 | Lewis-Hall Freda C Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-08-05 | Farley Chele Chiavacci Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-03 | Regan Andrew Chief Executive Officer | Grant or award | +154,799 | $3.23 | $500K | 154,799 |
| 2025-04-16 | Charles Faith L. Director | Grant or award | +115,194 | $0.87 | $100K | 165,238 |
| 2025-03-30 | Lewis-Hall Freda C Director | Grant or award | +47,612 | $0.89 | $42K | 51,991 |
| 2025-03-30 | Fry Simon Jeremy Director | Grant or award | +29,354 | $0.89 | $26K | 31,354 |
| 2025-03-30 | Farley Chele Chiavacci Director | Grant or award | +32,022 | $0.89 | $28K | 35,537 |
| 2025-03-30 | Charles Faith L. Director | Grant or award | +46,629 | $0.89 | $41K | 50,044 |
| 2024-12-18 | Lewis-Hall Freda C Director | Grant or award · Stock Option (Right to Buy) | +420,000 | $0.07 | $30K | 420,000 |
Page 2 of 5 · 90 trades